This month's top tech news stories
Kingston University
AI eye test
Artificial intelligence (AI)-enabled eye scans could be used to rapidly and accurately predict whether a person is at high risk of heart disease, a new study involving researchers from Kingston University has established. The findings could pave the way for cardiovascular screening without blood tests or blood pressure measurements. The AI-enabled imaging could specify the risk of cardiovascular disease and stroke and act as an alternative predictive biomarker.
Serosep
Diagnostic Kit
Serosep is changing the way labs process and handle the estimated 17 million cases of gastrointestinal infections in the UK each year. It has developed an innovative, molecular-based diagnostic kit for enteric testing – EntericBio provides a flexible, modular menu that is reliable, easy to use and provides rapid results direct from stool sample in three hours. The system processes 1–48 tests per run with no DNA/RNA extraction, automated setup and lyophilised ready-to-use assays.
Roche
Precision Medicine Trial
A multi-drug, precision medicine trial for people with rare cancers who need more treatment options has opened. Behind the trial are Cancer Research UK, The University of Manchester and Roche. It has been set up to recruit paediatric and adult patients with rare cancers and is one of very few precision medicine platform trials in the world targeting these populations. It aims to find out whether existing drugs, including those licensed for more common types of cancer, could also benefit patients with rare cancer types that the drug isn’t currently licensed for.
Image credit | Shutterstock | iStock
